Chu E, Chu TC and Potter DE (1999a) Potential sites of action of TNPA: A dopa- mine-2 receptor agonist. Exp Eye Res 69:611- 616.Chu, E., Chu, T.C., and Potter, D.E. Potential sites of action of TNPA: A dopamine-2 receptor agonist. Exp. Eye Res. 69:611-616, 1999....
At the same doses of 20, 100, 500 and 2000 nM, the dopamine-1 receptor agonist, fenoldopam, was much more potent than dopamine-2 receptor agonist, N-n-propyl-N-n-butyl dopamine (PBDA), in increasing CF. Under conditions of constant systemic arterial pressure, fenoldopam produced a ...
PHNO, a selective dopamine D[sub 2] receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Martin-Iverson MT and Else D (2000) PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats... Martin-Iverson...
This detrimental effect is reversed by the D2 DA receptor agonist quinpirole via the inhibition of the cAMP/PKA intracellular pathway. Analysis of mitochondrial functions in G2019S Lrrk2-expressing SH-SY5Y cells revealed strong rotenone-induced oxidative stress characterized by reduced Ca2+ buffering ...
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secre- tion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem Pharmacol 79: 1827–1836. Delaere F, Akaoka H, De Vadder F, Duchampt A, Mithieux G (2013). Portal glucose influences ...
Anti-Dopamine-2 receptor (D2R) antibodies have been recently identified in a subgroup of children with autoimmune movement and psychiatric disorders, however the epitope(s) and mechanism of pathogenicity remain unknown. Here we report a major biological
Depletion of catecholamines by pretreatment with the tyrosine hydroxylase inhibitor α-methyl-para-tyrosine attenuated the ability of the selective D-2 dopamine receptor agonist quinpirole to inhibit rat nucleus accumbens neurons when applied directly by microiontophoresis. Concurrent iontophoretic administration...
A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Peng RY, Mansbach RS, Braff DL, Geyer MA (1990) A D2 dopamine receptor agonist disrupts sensorimotor gating in rats: implications for dopaminergic ... RY Peng,RS Man...
The dopamine receptoragonistbromocriptinelowers IOP in human eyes when administered orally or topically.97,98This effect is blocked by intravenousmetoclopramide, a dopamine2antagonist, suggesting that this agonist is truly acting through dopamine receptors.97A selective dopamine1agonist, feno...
T., 1982, Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist, J. Pharmacol. Exp. Ther. 223:305–313. PubMed CAS Google Scholar Hashimoto, K., Satho, S., and Takeuchi, O., 1971, Effect of dopamine on pancreatic secretion in the ...